{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:56Z","timestamp":1786985216094,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bioorg.2025.108267","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T16:00:18Z","timestamp":1739548818000},"page":"108267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of a new hydrazone-oxamide hybrid capable of inducing necroptotic cell death in triple negative breast cancer cells"],"prefix":"10.1016","volume":"157","author":[{"given":"Romina","family":"Akhavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Jabari Harsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Shafiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahya","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheleh","family":"Tahmasvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Taghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Kooshafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiva","family":"Mohammadmirzaeizarandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Almasirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108267_bb0005","doi-asserted-by":"crossref","first-page":"20211033","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bioorg.2025.108267_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2025.108267_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121193","article-title":"Mechanisms of resistance to Chemotherapy in breast Cancer and possible targets in drug delivery systems","volume":"12","author":"Lainetti","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.108267_bb0020","series-title":"Cancer Chemotherapy, in: StatPearls, StatPearls Publishing Copyright \u00a9 2023","author":"Amjad","year":"2023"},{"key":"10.1016\/j.bioorg.2025.108267_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15171\/apb.2019.024","article-title":"Understanding apoptosis and apoptotic pathways targeted Cancer therapeutics","volume":"9","author":"Jan","year":"2019","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2025.108267_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis","volume":"14","author":"Su","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.108267_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112618","article-title":"Therapeutics targeting the Core apoptotic machinery","volume":"13","author":"Hamilton","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108267_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101056","article-title":"Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?","volume":"14","author":"Mollaei","year":"2021","journal-title":"Translational Oncology"},{"key":"10.1016\/j.bioorg.2025.108267_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113466","article-title":"The roles of autophagy in Cancer","volume":"19","author":"Yun","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108267_bb0050","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.apsb.2020.01.007","article-title":"Targeting necroptosis in anticancer therapy: mechanisms and modulators","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108267_bb0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy","volume":"18","author":"Gong","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.108267_bb0060","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cdd.2016.8","article-title":"Cancer therapy in the necroptosis era","volume":"23","author":"Su","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2025.108267_bb0065","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.2174\/1568026617666170707124126","article-title":"Multi-targeted anticancer agents","volume":"17","author":"Zheng","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0070","first-page":"451","article-title":"Molecular hybridization: a powerful tool for multitarget drug discovery, expert Opin","volume":"19","author":"de Sena Murteira","year":"2024","journal-title":"Drug Des. Discov."},{"key":"10.1016\/j.bioorg.2025.108267_bb0075","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00280-017-3318-5","article-title":"In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells","volume":"79","author":"Mousavi","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108267_bb0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cmdc.201900716","article-title":"Design, synthesis, and pharmacological evaluation of first-in-class multitarget N-Acylhydrazone derivatives as selective HDAC6\/8 and PI3K\u03b1 inhibitors","volume":"15","author":"Rodrigues","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108267_bb0085","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bmc.2019.02.002","article-title":"Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl)hydrazide-hydrazone derivatives","volume":"27","author":"Sreenivasulu","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00706-016-1750-6","article-title":"Synthesis, antitumor evaluation, and molecular docking studies of indole\u2013indazolyl hydrazide\u2013hydrazone derivatives","volume":"148","author":"Sreenivasulu","year":"2017","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.3653","article-title":"The first oxalamide-bridged ferrocene: facile synthesis, preliminary conformational analysis and biological evaluation","volume":"31","author":"Kova\u010d","year":"2017","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0100","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1039\/C9SC00910H","article-title":"Introduction of the \u03b1-ketoamide structure: en route to develop hydrogen peroxide responsive prodrugs","volume":"10","author":"Meng","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.108267_bb0105","doi-asserted-by":"crossref","first-page":"113267","DOI":"10.1016\/j.ejmech.2021.113267","article-title":"A new class of \u03b1-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities","volume":"215","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0110","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.bmcl.2005.11.101","article-title":"Novel, potent P2\u2013P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors","volume":"16","author":"Barrett","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0115","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1021\/acsomega.3c04749","article-title":"Structure-activity relationship study and design strategies of Hydantoin, thiazolidinedione, and Rhodanine-based kinase inhibitors: a two-decade review, ACS","volume":"9","author":"Naufal","year":"2024","journal-title":"Omega"},{"key":"10.1016\/j.bioorg.2025.108267_bb0120","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1016\/j.bmc.2011.08.051","article-title":"Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors","volume":"19","author":"Wilson","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2017.02.008","article-title":"Inhibitors of cyclin-dependent kinases as cancer therapeutics","volume":"173","author":"Whittaker","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.108267_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234103","article-title":"Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer","volume":"15","author":"Frame","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108267_bb0135","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/med.21856","article-title":"Analyzing the scaffold diversity of cyclin-dependent kinase inhibitors and revisiting the clinical and preclinical pipeline","volume":"42","author":"Bhurta","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108267_bb0140","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.ejmech.2010.02.045","article-title":"Synthesis and antiproliferative activity of oxazinocarbazole and N,N-bis(carbazolylmethyl)amine derivatives","volume":"45","author":"Issa","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0145","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1007\/s00210-023-02931-6","article-title":"In vitro and in vivo activity of a novel oxamide-hydrazone hybrid derivative against triple-negative breast cancer","volume":"397","author":"Tahmasvand","year":"2024","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108267_bb0150","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1021\/ol400870b","article-title":"Triflic anhydride mediated synthesis of imidazo[1,5-a]azines","volume":"15","author":"Pelletier","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108267_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ardp.200300822","article-title":"Synthesis and morphine enhancement activity of N-[5-(2-phenoxyphenyl)-1, 3, 4-oxadiazole-2-yl]-N\u2032-phenylurea derivatives","volume":"337","author":"Rad","year":"2004","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.108267_bb0160","first-page":"727","article-title":"Synthesis and Antimycobacterial activity of 2-(Phenylthio) benzoylarylhydrazone derivatives, Iran","volume":"10","author":"Almasirad","year":"2011","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.bioorg.2025.108267_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0076-6879(08)01606-6","article-title":"DNA damage response and apoptosis","volume":"446","author":"Plesca","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bioorg.2025.108267_bb0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-018-1235-0","article-title":"Necroptosis: a regulated inflammatory mode of cell death","volume":"15","author":"Dhuriya","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bioorg.2025.108267_bb0175","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1101\/gad.223321.113","article-title":"RIP3: a molecular switch for necrosis and inflammation","volume":"27","author":"Moriwaki","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2025.108267_bb0180","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3390\/biomedicines10071632","article-title":"The Cytoprotective, cytotoxic and nonprotective functional forms of autophagy induced by microtubule poisons in tumor cells—implications for autophagy modulation as a therapeutic strategy","volume":"10","author":"Xu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.108267_bb0185","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108267_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2025.108267_bb0195","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.bioorg.2025.108267_bb0200","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10495-017-1358-2","article-title":"RIPK1\/RIPK3\/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death","volume":"22","author":"Chen","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2025.108267_bb0205","doi-asserted-by":"crossref","first-page":"50818","DOI":"10.18632\/oncotarget.10640","article-title":"Autophagy complexes cell death by necroptosis","volume":"7","author":"Goodall","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.108267_bb0210","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1111\/febs.13515","article-title":"Recent insights into cell death and autophagy","volume":"282","author":"Fitzwalter","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2025.108267_bb0215","series-title":"Autophagosome and Phagosome","first-page":"77","article-title":"LC3 and autophagy","author":"Tanida","year":"2008"},{"key":"10.1016\/j.bioorg.2025.108267_bb0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13065-022-00873-3","article-title":"Design and synthesis of novel ureido and thioureido conjugated hydrazone derivatives with potent anticancer activity","volume":"16","author":"Koopaei","year":"2022","journal-title":"BMC Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104276","article-title":"Design and synthesis of novel 4-thiazolidinone derivatives with promising anti-breast cancer activity: synthesis, characterization, in vitro and in vivo results","volume":"104","author":"Tahmasvand","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108267_bb0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40659-019-0247-2","article-title":"A novel hydrazide compound exerts anti-metastatic effect against breast cancer","volume":"52","author":"Dehghani","year":"2019","journal-title":"Biol. Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T21:33:57Z","timestamp":1763847237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":46,"alternative-id":["S0045206825001476"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108267","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a new hydrazone-oxamide hybrid capable of inducing necroptotic cell death in triple negative breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108267"}}